Pilot study for immunoglobulin E as a prognostic biomarker in coronavirus disease 2019

…, NA Acet Ozturk, E Demirdogen… - Internal Medicine …, 2022 - Wiley Online Library
… Our single-centre pilot study determined that total IgE levels may be a negative prognostic
factor for … Our single-centre pilot study determined that total IgE levels may be a negative …

[PDF][PDF] Pilot study for immunoglobulin E as a prognostic biomarker in coronavirus disease 2019.

…, AG Dilektasli, NAA Ozturk, E Demirdogen… - Internal Medicine …, 2022 - researchgate.net
… Conclusions: Our single-centre pilot study determined that total IgE levels may be a negative
prognostic … Our single-centre pilot study determined that total IgE levels may be a negative …

Pilot study for immunoglobulin E as a prognostic biomarker in coronavirus disease 2019.

SS Goktas, AO NA, E Demirdogen, F Coskun… - Internal Medicine …, 2022 - europepmc.org
… In the present study, we aim to evaluate the effects of basal serum total immunoglobulin
E (IgE) levels … parameters on the clinical progression of patients hospitalized with COVID‐19. …

Effects of adjunct treatment with intravenous immunoglobulins on the course of severe COVID-19: results from a retrospective cohort study

…, İ Anaklı, G Alay, V Tuna, E Çeliksoy… - … medical research …, 2021 - Taylor & Francis
… to our local SIC had any measurable effect on clinical outcomes and biomarkers in these …
were compared regarding baseline characteristics, prognostic factors, treatments, diagnostics …

Immunological Biomarkers in Blood to Monitor the Course and Therapeutic Outcomes of COVID-19

E Wieland - Therapeutic Drug Monitoring, 2022 - journals.lww.com
… options, and laboratory monitoring tools for diagnosis, prognosis, and surveillance. This
review focuses on immune biomarkers that can be measured in peripheral blood in a clinical …

Predictive monitoring and therapeutic immune biomarkers in the management of clinical complications of COVID-19

H Fouladseresht, M Doroudchi, N Rokhtabnak… - Cytokine & growth factor …, 2021 - Elsevier
… The coronavirus disease-2019 (COVID-19), caused by severe acute respiratory syndrome …
a potential predictive marker of response to treatment and pulmonary complications in COVID-…

Characterization by quantitative serum proteomics of immune-related prognostic biomarkers for COVID-19 symptomatology

…, N Jiménez-Collados, E Ferreras-Colino… - Frontiers in …, 2021 - frontiersin.org
… collected prior to the COVID-19 pandemic in April 2019. … biomarkers identified in this study
provide clinical tools for the evaluation and treatment of SARS-CoV-2 infection and disease

Salivary biomarkers in COVID-19 patients: Towards a wide-scale test for monitoring disease activity

…, C Callà, A Fiorita, M Marino, E Taddei… - Journal of personalized …, 2021 - mdpi.com
coronavirus 2 (SARS-CoV-2) emerged in late 2019 in the city … pneumonia named ’coronavirus
disease 2019′ (COVID-19) … Being highly transmissible, this novel coronavirus disease

Endothelial, immunothrombotic, and inflammatory biomarkers in the risk of mortality in critically ill COVID-19 patients: the role of dexamethasone

C Keskinidou, AG Vassiliou, A Zacharis, E Jahaj… - Diagnostics, 2021 - mdpi.com
… However, the effect of dexamethasone has not been investigated on these biomarkers.
Hence, we studied potential prognostic biomarkers of mortality in critically ill COVID-19 patients …

Contribution of coronavirus-specific immunoglobulin G responses to complement overactivation in patients with severe coronavirus disease 2019

PMS Castanha, DJ Tuttle, GD Kitsios… - … infectious diseases, 2022 - academic.oup.com
… Markers of complement activation are increased in patients with coronavirus disease 2019
(COVID-19) and are associated with disease severity. Plasma levels of various markers of …